1. Home
  2. NVNO vs PBHC Comparison

NVNO vs PBHC Comparison

Compare NVNO & PBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNO
  • PBHC
  • Stock Information
  • Founded
  • NVNO 1987
  • PBHC 1859
  • Country
  • NVNO United States
  • PBHC United States
  • Employees
  • NVNO N/A
  • PBHC N/A
  • Industry
  • NVNO Medical/Dental Instruments
  • PBHC Major Banks
  • Sector
  • NVNO Health Care
  • PBHC Finance
  • Exchange
  • NVNO Nasdaq
  • PBHC Nasdaq
  • Market Cap
  • NVNO 78.7M
  • PBHC 92.1M
  • IPO Year
  • NVNO N/A
  • PBHC N/A
  • Fundamental
  • Price
  • NVNO $4.05
  • PBHC $14.61
  • Analyst Decision
  • NVNO
  • PBHC
  • Analyst Count
  • NVNO 0
  • PBHC 0
  • Target Price
  • NVNO N/A
  • PBHC N/A
  • AVG Volume (30 Days)
  • NVNO 135.7K
  • PBHC 7.0K
  • Earning Date
  • NVNO 07-30-2025
  • PBHC 07-28-2025
  • Dividend Yield
  • NVNO N/A
  • PBHC 2.74%
  • EPS Growth
  • NVNO N/A
  • PBHC N/A
  • EPS
  • NVNO N/A
  • PBHC 0.53
  • Revenue
  • NVNO N/A
  • PBHC $41,317,000.00
  • Revenue This Year
  • NVNO N/A
  • PBHC N/A
  • Revenue Next Year
  • NVNO $409.09
  • PBHC N/A
  • P/E Ratio
  • NVNO N/A
  • PBHC $27.73
  • Revenue Growth
  • NVNO N/A
  • PBHC 1.46
  • 52 Week Low
  • NVNO $2.03
  • PBHC $12.30
  • 52 Week High
  • NVNO $6.48
  • PBHC $19.86
  • Technical
  • Relative Strength Index (RSI)
  • NVNO 54.46
  • PBHC 41.32
  • Support Level
  • NVNO $4.19
  • PBHC $14.81
  • Resistance Level
  • NVNO $4.52
  • PBHC $15.95
  • Average True Range (ATR)
  • NVNO 0.39
  • PBHC 0.27
  • MACD
  • NVNO -0.01
  • PBHC -0.06
  • Stochastic Oscillator
  • NVNO 47.29
  • PBHC 0.00

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

Share on Social Networks: